Controversial Alzheimer’s drug may value US $334B—practically half of DoD finances

Enlarge / Pedestrians stroll previous Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Biogen Inc. shares soared after its controversial Alzheimer’s illness remedy was authorized by US… Read more